Kastritis, Efstathios http://orcid.org/0000-0001-8191-5832
Buske, Christian http://orcid.org/0000-0002-9782-9012
Article History
Received: 29 January 2024
Revised: 19 February 2024
Accepted: 20 February 2024
First Online: 7 March 2024
Competing interests
: Christian Buske: honoraria: Roche/Genentech, Janssen, BeiGene, Novartis, Pfizer, AbbVie, Gilead Sciences, Celltrion, MorphoSys, Regeneron, Hexal, Bayer, SOBI; consulting or advisory role: Gilead Sciences, Janssen, Roche, Pfizer, BeiGene, Celltrion, AbbVie, Regeneron, MorphoSys, Novartis, Bayer, SOBI; speakers' bureau: Roche, Janssen, BeiGene, Celltrion, AbbVie, Pfizer, Gilead Sciences, Bayer, Hexal, MorphoSys, Regeneron, Novartis; research funding: Roche/Genentech, Janssen, Celltrion, MSD, Amgen, Bayer (Inst), AbbVie, Pfizer. Efstathios Kastritis: honoraria: Janssen, GSK, Pfizer, Sanofi; research support: Janssen, GSK, Pfizer; travel support: Janssen, Sanofi.